Dinutuximab beta

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

Soft Tissue SarcomaNeuroblastomaOsteosarcomaHigh-Risk Neuroblastoma

258 competitors in Soft Tissue Sarcoma

#DrugCompanyPhaseTrials

1

Adriamycin

Pfizer

Phase 3

342

Votrient

Novartis

Phase 3

163

Ifex

BBaxter Healthcare Corporation

Phase 3

324

Gemzar

Johnson & Johnson

Phase 3

115

Yondelis

AApotex Inc.

Phase 3

176

Halaven

Eisai

Phase 3

37

Neulasta

Amgen

Phase 3

28

Ellence

Pfizer

Phase 3

29

Taxotere

AAvyxa

Phase 3

1010

Cytoxan

BBaxter Healthcare Corporation

Phase 3

7Show 39 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Neuroblastoma7 trials

High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)

Recruiting·GGustave Roussy, Cancer Campus, Grand Paris·Phase 3·NCT04221035·800 enrolled

A Multi-Arm, Platform Trial For Relapsed Neuroblastoma

Recruiting·UUniversity of Birmingham·Phase 1/2·NCT07334301·160 enrolled

Quadruple Immunotherapy for Neuroblastoma

Recruiting·HHong Kong Children's Hospital·Phase 2·NCT05754684·29 enrolled

Show 4 more trials

Study Combining Dinutuximab Beta With Two Chemotherapy Regimens in Neuroblastoma

Recruiting·PPrincess Maxima Center for Pediatric Oncology·Phase 1·NCT06485947·38 enrolled

Phase II Study of Monoclonal Antibody ch14.18/CHO Continuous Infusion in Patients With Primary Refractory or Relapsed Neuroblastoma

Unknown status·UUniversity Medicine Greifswald·Phase 2·NCT02743429·40 enrolled

Activity Study of Bevacizumab With Temozolomide ± Irinotecan for Neuroblastoma in Children

Active, not recruiting·UUniversity of Birmingham·Phase 2·NCT02308527·225 enrolled

Evaluation of the Safety and Pharmacokinetics of Dinutuximab Beta As Maintenance Therapy in Chinese Participants With High-Risk Neuroblastoma

Completed·BeiGene·Phase 1·NCT05373901·8 enrolled

Trial1 trial

International Phase I Trial of Dinutuximab Beta With VDC/IE in GD2-Positive Ewing Sarkoma

Not yet recruiting·—·Phase 1·NCT06839703·18 enrolled

Soft Tissue Sarcoma1 trial

Chemo-immunotherapy in Patients Under 18 Years of Age With Bone and Soft Tissue Sarcomas

Recruiting·NN.N. Petrov National Medical Research Center of Oncology·Phase 3·NCT06669013·40 enrolled

Osteosarcoma1 trial

Qarziba for Patients in Relapsed/Refractory High-grade Osteosarcoma

Suspended·PProf. Franca Fagioli·Phase 2·NCT05558280·22 enrolled

High-Risk Neuroblastoma1 trial

Pilot Study of Combining of Dinutuximab-β With Induction Chemotherapy in Newly Diagnosed High Risk Neuroblastoma

Not yet recruiting·CChang Gung Memorial Hospital·Phase 1·NCT07688252·30 enrolled

Details

Drug Info

Related News